{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T13:45:45Z","timestamp":1791812745370,"version":"4.3.4"},"reference-count":138,"publisher":"Wiley","issue":"11","license":[{"start":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T00:00:00Z","timestamp":1787875200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T00:00:00Z","timestamp":1787875200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"funder":[{"DOI":"10.13039\/100008272","name":"Novartis Pharmaceuticals Corporation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008272","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["American J Hematol"],"published-print":{"date-parts":[[2026,11]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:p>Current treatments for immune thrombocytopenia (ITP) and warm autoimmune hemolytic anemia (wAIHA), rare autoimmune diseases in which autoreactive B cells play a major role, can lead to high response rates; however, for many patients these responses are not durable or maintained after treatment discontinuation. Binding of B\u2010cell\u2010activating factor (BAFF) to its receptor (BAFF\u2010R) has been shown to lead to B\u2010cell differentiation, proliferation, and survival, with BAFF levels shown to be elevated in patients with ITP and wAIHA. Targeting the BAFF\/BAFF\u2010R pathway could address unmet needs that remain for patients with ITP and wAIHA despite available treatments.<\/jats:p>","DOI":"10.1002\/ajh.70460","type":"journal-article","created":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T08:08:11Z","timestamp":1787904491000},"page":"2836-2852","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Targeting B\u2010Cell\u2010Activating Factor and Its Receptor in Immune Thrombocytopenia and Warm Autoimmune Hemolytic Anemia"],"prefix":"10.1002","volume":"101","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9182-1434","authenticated-orcid":false,"given":"Matthieu","family":"Mah\u00e9vas","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, National Referral Center for Autoimmune Cytopenias Cr\u00e9teil University Hospital  Cr\u00e9teil France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9845-8292","authenticated-orcid":false,"given":"Nichola","family":"Cooper","sequence":"additional","affiliation":[{"name":"Department of Inflammation and Immunity Imperial College London  London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4392-8223","authenticated-orcid":false,"given":"Vickie","family":"McDonald","sequence":"additional","affiliation":[{"name":"Department of Clinical Haematology Guy's and St Thomas' NHS Foundation Trust  London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1968-0101","authenticated-orcid":false,"given":"Karina","family":"Yazdanbakhsh","sequence":"additional","affiliation":[{"name":"Lindsley F Kimball Research Institute New York Blood Center  New York New York USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1428-9944","authenticated-orcid":false,"given":"Wilma","family":"Barcellini","sequence":"additional","affiliation":[{"name":"Department of Hematology Fondazione IRCCS Ca\u2019 Granda Ospedale Maggiore Policlinico  Milan Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2026,8,28]]},"reference":[{"key":"e_1_2_11_2_1","doi-asserted-by":"publisher","DOI":"10.3390\/jcm10051004"},{"key":"e_1_2_11_3_1","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines12071597"},{"key":"e_1_2_11_4_1","doi-asserted-by":"publisher","DOI":"10.3390\/ph15070779"},{"key":"e_1_2_11_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2022.103820"},{"key":"e_1_2_11_6_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra2033982"},{"key":"e_1_2_11_7_1","doi-asserted-by":"publisher","DOI":"10.12703\/P6\u201045"},{"key":"e_1_2_11_8_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.21616"},{"key":"e_1_2_11_9_1","doi-asserted-by":"publisher","DOI":"10.3390\/jcm9123859"},{"key":"e_1_2_11_10_1","doi-asserted-by":"publisher","DOI":"10.2147\/CLEP.S250250"},{"key":"e_1_2_11_11_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.26213"},{"key":"e_1_2_11_12_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMcp1810479"},{"key":"e_1_2_11_13_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood\u20102017\u201003\u2010754119"},{"key":"e_1_2_11_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.hoc.2013.03.001"},{"key":"e_1_2_11_15_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.26036"},{"key":"e_1_2_11_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.blre.2019.100648"},{"key":"e_1_2_11_17_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.17217"},{"key":"e_1_2_11_18_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood\u20102024\u2010208446"},{"key":"e_1_2_11_19_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2019000812"},{"key":"e_1_2_11_20_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2019000966"},{"key":"e_1_2_11_21_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2021010968"},{"key":"e_1_2_11_22_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood\u20102015\u201007\u2010659656"},{"key":"e_1_2_11_23_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood\u20102011\u201011\u2010393975"},{"key":"e_1_2_11_24_1","doi-asserted-by":"publisher","DOI":"10.1097\/SLA.0000000000001912"},{"key":"e_1_2_11_25_1","doi-asserted-by":"publisher","DOI":"10.1159\/000442703"},{"key":"e_1_2_11_26_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood\u20102023\u2010188527"},{"key":"e_1_2_11_27_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.HS9.0000973232.36093.e7"},{"key":"e_1_2_11_28_1","doi-asserted-by":"publisher","DOI":"10.3390\/jcm9124034"},{"key":"e_1_2_11_29_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2019003808"},{"key":"e_1_2_11_30_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood\u20102010\u201003\u2010259325"},{"key":"e_1_2_11_31_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.10062"},{"key":"e_1_2_11_32_1","doi-asserted-by":"publisher","DOI":"10.1182\/hematology.2022000405"},{"key":"e_1_2_11_33_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.12541"},{"key":"e_1_2_11_34_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.24570"},{"key":"e_1_2_11_35_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.23767"},{"key":"e_1_2_11_36_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V130.Suppl_1.3370.3370"},{"key":"e_1_2_11_37_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood\u20102024\u2010207786"},{"key":"e_1_2_11_38_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2013.01.046"},{"key":"e_1_2_11_39_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrrheum.2009.141"},{"key":"e_1_2_11_40_1","doi-asserted-by":"publisher","DOI":"10.3390\/cells10051190"},{"key":"e_1_2_11_41_1","doi-asserted-by":"publisher","DOI":"10.1186\/ar3918"},{"key":"e_1_2_11_42_1","doi-asserted-by":"publisher","DOI":"10.1038\/nature03724"},{"key":"e_1_2_11_43_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1624667"},{"key":"e_1_2_11_44_1","doi-asserted-by":"publisher","DOI":"10.3390\/hematolrep16020021"},{"key":"e_1_2_11_45_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.1086907"},{"key":"e_1_2_11_46_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI84009"},{"key":"e_1_2_11_47_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood\u20102014\u201003\u2010563445"},{"key":"e_1_2_11_48_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41584\u2010019\u20100211\u20100"},{"key":"e_1_2_11_49_1","doi-asserted-by":"publisher","DOI":"10.3390\/jcm10040789"},{"key":"e_1_2_11_50_1","doi-asserted-by":"publisher","DOI":"10.1160\/TH07\u201008\u20100513"},{"key":"e_1_2_11_51_1","doi-asserted-by":"publisher","DOI":"10.3390\/jcm6020016"},{"key":"e_1_2_11_52_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2022018380"},{"key":"e_1_2_11_53_1","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/363278"},{"key":"e_1_2_11_54_1","doi-asserted-by":"publisher","DOI":"10.1080\/1744666X.2022.2089115"},{"key":"e_1_2_11_55_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12979\u2010020\u201000208\u20107"},{"key":"e_1_2_11_56_1","doi-asserted-by":"publisher","DOI":"10.18553\/jmcp.2020.26.7.832"},{"key":"e_1_2_11_57_1","unstructured":"Genentech \u201cRITUXAN \u201dPrescribing Information 2021 accessed January 14 2026 https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2021\/103705s5467lbl.pdf."},{"key":"e_1_2_11_58_1","unstructured":"Roche \u201cMABTHERA \u201dSummary of Product Characteristics 2024 accessed January 14 2026 https:\/\/www.ema.europa.eu\/en\/documents\/product\u2010information\/mabthera\u2010epar\u2010product\u2010information_en.pdf."},{"key":"e_1_2_11_59_1","doi-asserted-by":"publisher","DOI":"10.1038\/nri2572"},{"key":"e_1_2_11_60_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrrheum.2014.33"},{"key":"e_1_2_11_61_1","doi-asserted-by":"publisher","DOI":"10.1038\/bcj.2015.3"},{"key":"e_1_2_11_62_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ceb.2017.10.002"},{"key":"e_1_2_11_63_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.coi.2021.06.014"},{"key":"e_1_2_11_64_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2022.111019"},{"key":"e_1_2_11_65_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood\u20102008\u201010\u2010183467"},{"key":"e_1_2_11_66_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2012.11.015"},{"key":"e_1_2_11_67_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood\u20102014\u201010\u2010606988"},{"key":"e_1_2_11_68_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2013.10.022"},{"key":"e_1_2_11_69_1","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.5040\u201008.2009"},{"key":"e_1_2_11_70_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.179.11.7276"},{"key":"e_1_2_11_71_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.02285"},{"key":"e_1_2_11_72_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.21489"},{"key":"e_1_2_11_73_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.173.2.807"},{"key":"e_1_2_11_74_1","doi-asserted-by":"publisher","DOI":"10.1097\/CJI.0000000000000209"},{"key":"e_1_2_11_75_1","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.183400"},{"key":"e_1_2_11_76_1","doi-asserted-by":"publisher","DOI":"10.1038\/ni842"},{"key":"e_1_2_11_77_1","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20060990"},{"key":"e_1_2_11_78_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood\u20102007\u201003\u2010077222"},{"key":"e_1_2_11_79_1","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20142127"},{"key":"e_1_2_11_80_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0805460105"},{"key":"e_1_2_11_81_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0005456"},{"key":"e_1_2_11_82_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2004.05.010"},{"key":"e_1_2_11_83_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0903543106"},{"key":"e_1_2_11_84_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365\u20102141.2006.06431.x"},{"key":"e_1_2_11_85_1","doi-asserted-by":"publisher","DOI":"10.1080\/08916930802397848"},{"key":"e_1_2_11_86_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood\u20102009\u201005\u2010217513"},{"key":"e_1_2_11_87_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12185\u2010015\u20101851\u20108"},{"key":"e_1_2_11_88_1","doi-asserted-by":"publisher","DOI":"10.1177\/0961203315608254"},{"key":"e_1_2_11_89_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard.62.2.168"},{"key":"e_1_2_11_90_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood\u20102017\u201006\u2010789578"},{"key":"e_1_2_11_91_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI65689"},{"key":"e_1_2_11_92_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2015.05.006"},{"key":"e_1_2_11_93_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.38074"},{"key":"e_1_2_11_94_1","doi-asserted-by":"publisher","DOI":"10.1038\/ni.2194"},{"key":"e_1_2_11_95_1","doi-asserted-by":"publisher","DOI":"10.1002\/cti2.1399"},{"key":"e_1_2_11_96_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.biocel.2022.106231"},{"key":"e_1_2_11_97_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2020.259481"},{"key":"e_1_2_11_98_1","unstructured":"GlaxoSmithKline \u201cBENLYSTA \u201dSummary of Product Characteristics. 2025 accessed January 14 2026 https:\/\/www.ema.europa.eu\/en\/documents\/product\u2010information\/benlysta\u2010epar\u2010product\u2010information_en.pdf."},{"key":"e_1_2_11_99_1","unstructured":"GlaxoSmithKline \u201cBENLYSTA \u201dPrescribing Information. 2024 accessed January 14 2026 https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2024\/125370s081lbl.pdf."},{"key":"e_1_2_11_100_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2018025684"},{"key":"e_1_2_11_101_1","doi-asserted-by":"publisher","DOI":"10.1080\/19420862.2018.1466767"},{"key":"e_1_2_11_102_1","unstructured":"FDA \u201cSearch Orphan Drug Designations and Approvals \u201daccessed January 14 2026 https:\/\/www.accessdata.fda.gov\/scripts\/opdlisting\/oopd\/detailedIndex.cfm?cfgridkey=1018924."},{"key":"e_1_2_11_103_1","unstructured":"ClinicalTrials.gov \u201cNCT05653219. A Study of Efficacy and Safety of Ianalumab Versus Placebo in Addition to Eltrombopag in Primary Immune Thrombocytopenia Patients Who Failed Steroids (VAYHIT2) \u201daccessed January 14 2026 https:\/\/clinicaltrials.gov\/study\/NCT05653219."},{"key":"e_1_2_11_104_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2515168"},{"key":"e_1_2_11_105_1","unstructured":"ClinicalTrials.gov \u201cNCT05885555. A Study of Ianalumab (VAY736) in Patients With Primary Immune Thrombocytopenia (ITP) Previously Treated With at Least Two Lines of Therapies \u201daccessed January 14 2026 https:\/\/clinicaltrials.gov\/study\/NCT05885555."},{"key":"e_1_2_11_106_1","unstructured":"C.Bradbury T.Elverdi K.Trautmann andM.Rummel \u201cA Phase 2 Study of Ianalumab in Patients With Primary Immune Thrombocytopenia Previously Treated With at Least Two Lines of Therapy (VAYHIT3) \u201d paper presented at European Hematology Association (EHA) 2025 Congress Milan Italy June 12\u201315 2025 Oral S312."},{"key":"e_1_2_11_107_1","doi-asserted-by":"crossref","unstructured":"P.Choi C.Bradbury T.Jose Gonzalez\u2010Lopez et\u00a0al. \u201cSecondary Analysis Results From VAYHIT3 a Phase 2 Study of Ianalumab in Patients with Primary Immune Thrombocytopenia Previously Treated with at Least Two Lines of Therapy \u201d 67th American Society of Hemalotolgy (ASH) Meeting. Orlando Florida USA 6\u20139 December 2025; abstract abs25\u20108745.","DOI":"10.1182\/blood-2025-844"},{"key":"e_1_2_11_108_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.HS9.0000976904.28542.f2"},{"key":"e_1_2_11_109_1","unstructured":"ClinicalTrials.gov \u201cNCT05648968. A Study of Efficacy and Safety of Ianalumab in Previously Treated Patients With Warm Autoimmune Hemolytic Anemia (VAYHIA) \u201daccessed January 14 2026 https:\/\/clinicaltrials.gov\/study\/NCT05648968."},{"key":"e_1_2_11_110_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ard.2025.11.015"},{"key":"e_1_2_11_111_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood\u20102023\u2010179305"},{"key":"e_1_2_11_112_1","unstructured":"ClinicalTrials.gov \u201cNCT06853444. A Phase 1\/2 Study of ESG206 in Patients With Primary Immune Thrombocytopenia \u201daccessed January 14 2026 https:\/\/clinicaltrials.gov\/study\/NCT06853444."},{"key":"e_1_2_11_113_1","doi-asserted-by":"crossref","unstructured":"Y.Hou X.Zhang H.Zhu et\u00a0al. \u201cInterim Report of a Phase 1\/2 Study of ESG206 in Patients With Refractory or Relapsed Primary Immune Thrombocytopenia \u201d67th American Society of Hemalotolgy (ASH) Meeting Orlando Florida USA 6\u20139 December 2025; abstract abs25\u20109338.","DOI":"10.1182\/blood-2025-3039"},{"key":"e_1_2_11_114_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.30613"},{"key":"e_1_2_11_115_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140\u20106736(10)61354\u20102"},{"key":"e_1_2_11_116_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard\u20102023\u2010224762"},{"key":"e_1_2_11_117_1","unstructured":"ClinicalTrials.gov \u201cNCT05338190. Efficacy and Safety of Subcutaneous Belimumab or Placebo in Addition of Rituximab in Persistent or Chronic Immune Thrombocytopenia (RITUX\u2010PLUS 2) \u201daccessed January 14 2026 https:\/\/clinicaltrials.gov\/study\/NCT05338190."},{"key":"e_1_2_11_118_1","unstructured":"ClinicalTrials.gov \u201cNCT01440361. A Study to Investigate Belimumab for the Treatment of Chronic Immune Thrombocytopenia \u201daccessed January 14 2026 https:\/\/clinicaltrials.gov\/study\/NCT01440361."},{"key":"e_1_2_11_119_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V122.21.4185.4185"},{"key":"e_1_2_11_120_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis\u20102018\u2010214720"},{"key":"e_1_2_11_121_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.HS9.0000977188.95345.32"},{"key":"e_1_2_11_122_1","doi-asserted-by":"crossref","unstructured":"H.Al\u2010Samkari A.Cuker F.Zaja et\u00a0al. \u201cPrimary Results From VAYHIT2 a Randomized Double\u2010Blind Phase 3 Trial of Ianalumab Plus Eltrombopag Versus Placebo Plus Eltrombopag in Patients With Primary Immune Thrombocytopenia (ITP) Who Failed First\u2010Line Corticosteroid Treatment \u201d67th American Society of Hematology (ASH) Meeting Orlando Florida USA 6\u20139 December 2025; abstract LBA\u20102.","DOI":"10.1182\/blood-2025-LBA-2"},{"key":"e_1_2_11_123_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.HS9.0000977232.29155.a4"},{"key":"e_1_2_11_124_1","unstructured":"ClinicalTrials.gov \u201cNCT05653349. Study of Ianalumab Versus Placebo in Addition to First\u2010Line Corticosteroids in Primary Immune Thrombocytopenia (ITP) (VAYHIT1) \u201daccessed January 14 2026 https:\/\/clinicaltrials.gov\/study\/NCT05653349."},{"key":"e_1_2_11_125_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140\u20106736(21)02251\u20100"},{"key":"e_1_2_11_126_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.43059"},{"key":"e_1_2_11_127_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis\u20102023\u2010eular.3389"},{"key":"e_1_2_11_128_1","unstructured":"T.Grader\u2010Beck X.Mariette S.Finzel et\u00a0al. \u201cIanalumab Demonstrates Significant Reduction in Disease Activity in Patients With Sj\u00f6gren's Disease: Efficacy and Safety Results From Two Global Phase 3 Randomized Placebo\u2010Controlled Double\u2010Blind Studies (NEPTUNUS\u20101 and NEPTUNUS\u20102) \u201dAmerican College of Rheumatology (ACR) Congress. Chicago Illinois USA 24\u201329 October 2025 abstract LB24."},{"key":"e_1_2_11_129_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood\u20102023\u2010177786"},{"key":"e_1_2_11_130_1","unstructured":"ClinicalTrials.gov \u201cNCT05757570. An Open\u2010Label Study of Povetacicept in Participants With Autoimmune Cytopenias (RUBY\u20104) \u201daccessed January 14 2026 https:\/\/clinicaltrials.gov\/study\/NCT05757570."},{"key":"e_1_2_11_131_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2024.42.16_suppl.e19000"},{"key":"e_1_2_11_132_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis\u20102013\u2010205144"},{"key":"e_1_2_11_133_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis\u20102018\u2010213032"},{"key":"e_1_2_11_134_1","unstructured":"ClinicalTrials.gov \u201cNCT01609452. MONICA\u2010SC: A Study to Evaluate the Efficacy Safety and Tolerability of Blisibimod (A\u2010623) Administration in Subjects With ITP \u201daccessed January 14 2026 https:\/\/clinicaltrials.gov\/study\/NCT01609452."},{"key":"e_1_2_11_135_1","unstructured":"ClinicalTrials.gov \u201cNCT06340750. BAFF CAR\u2010T Cells (LMY\u2010920) for Systemic Lupus Erythematosus \u201daccessed January 14 2026 https:\/\/clinicaltrials.gov\/study\/NCT06340750."},{"key":"e_1_2_11_136_1","unstructured":"ClinicalTrials.gov \u201cNCT06189157. MB\u2010CART19.1 in Refractory SLE \u201daccessed January 14 2026 https:\/\/clinicaltrials.gov\/study\/NCT06189157."},{"key":"e_1_2_11_137_1","unstructured":"ClinicalTrials.gov \u201cNCT06279923. CD19\u2010BAFF CAR\u2010T Cells Therapy for Patients With Autoimmune Diseases \u201daccessed January 14 2026 https:\/\/clinicaltrials.gov\/study\/NCT06279923."},{"key":"e_1_2_11_138_1","unstructured":"ClinicalTrials.gov \u201cNCT05459870. CAR\u2010T Cells Targeting Autoimmune Diseases \u201daccessed January 14 2026 https:\/\/clinicaltrials.gov\/study\/NCT05459870."},{"key":"e_1_2_11_139_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2025017279"}],"container-title":["American Journal of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/ajh.70460","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/ajh.70460","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/ajh.70460","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T12:57:17Z","timestamp":1791809837000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/ajh.70460"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,28]]},"references-count":138,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["10.1002\/ajh.70460"],"URL":"https:\/\/doi.org\/10.1002\/ajh.70460","archive":["Portico"],"relation":{},"ISSN":["0361-8609","1096-8652"],"issn-type":[{"value":"0361-8609","type":"print"},{"value":"1096-8652","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,28]]},"assertion":[{"value":"2025-08-29","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-07-22","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-08-28","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}